Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMTX
#2196
Immatics N.V. Ordinary Shares
10.950
0
USD
+0.74%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.74%
Monthly Change
+16.00%
6 month change
+5.80%
Year Change
+5.80%
Previous Close
10.870
0
Open
10.950
0
Bid
Ask
Low
10.950
0
High
10.950
0
Volume
19
Markets
US Stock Market
Healthcare
IMTX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Market Capitalization
1.4681 B
Employee
407
Founded
2000
CEO
Harpreet Singh
Website
www.immatics.com
Headquarter
Netherlands
FIGI
N/A
Industry
Technology
Total revenue
0
1.47 B
Market capitalization
Net income
0
News
Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)
Immatics NV earnings beat by €0.13, revenue topped estimates
Nuvation Bio Inc. (NUVB) Reports Q4 Loss, Beats Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
Immatics Stock: PRAME Leader’s Transition To Commercial Reality (NASDAQ:IMTX)
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Salesforce and Micron Tech among market cap stock movers on Friday
Micron, Salesforce among market cap stock movers on Friday
Immatics stock price target raised to $17 from $16 at Leerink Partners
Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)
Company News for Nov 18, 2025
Guggenheim raises Immatics stock price target to $19 on positive TCR pipeline data